HomeNewsNeuroscience

  • Sanofi launches multiple sclerosis drug Aubagio in India

    • August 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Positive Clinical Results announced for LRRK2 in Parkinson’s Disease

    • August 6, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA Approves Perseris (risperidone) for Schizophrenia treatment in Adults

    • August 6, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Novartis wins Aimovig approval for launch in the EU markets

    • August 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Roche receives FDA’s breakthrough status for its new Alzheimer’s biomarker

    • July 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Bill Gates invests $30m on affordable Alzheimer’s test

    • July 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Unprecedented demand for Aimovig reflects strong unmet need in Migraine, says Novartis CEO

    • July 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Antiherpetic medications reduce Alzheimer’s dementia risk by a factor of 10, says latest research

    • July 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Positive Ph 3 results announced for Zogenix’s ZX008 in Epilepsy Trial

    • July 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Herantis initiates CDNF development program for Parkinson’s disease

    • July 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more